BioE Names National Marrow Donor Program Medical Director to Board of Directors; Dr. John P. Miller's Extensive Clinical Knowledge Will Help BioE Strengthen Its Business by Facilitating the Use of Cord Blood to Enhance Patient Outcomes.ST. PAUL, Minn. -- BioE(R), Inc., a biomedical bi·o·med·i·cal adj. 1. Of or relating to biomedicine. 2. Of, relating to, or involving biological, medical, and physical sciences. company providing human cord blood stem cells cord blood stem cells Umbilical cord blood Hematology A therapeutic 'agent' containing concentrated hematopoietic stem cells for Pts with BM depleted–'wiped out' by disease; they are transfused into HLA-identical siblings and used to reconstitute the BM of as enabling, high-quality cellular tools for drug discovery and therapeutic research, announced today it named John P. Miller, M.D., Ph.D. and medical director of the National Marrow Donor Program's Donor Medical Services, to its board of directors. The National Marrow Donor Program The National Marrow Donor Program (NMDP) is a nonprofit organization based in Minneapolis, Minnesota, that operates the federally funded registry of volunteer hematopoietic cell donors in the United States. These potential donors, numbering more than 6. (NMDP NMDP National Marrow Donor Program NMDP National Missile Defense Program ) helps individuals who need a life-saving marrow or blood cell transplant by connecting patients, doctors, donors and researchers with resources they need to help more people live longer, healthier lives. "John is a perfect fit for our board of directors," said Michael Haider, president and chief executive officer (CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. ) for BioE. "Having someone with John's extensive clinical knowledge and industry experience will be a tremendous asset as we develop our stem cell stem cell In living organisms, an undifferentiated cell that can produce other cells that eventually make up specialized tissues and organs. There are two major types of stem cells, embryonic and adult. products to facilitate the successful processing, storage and clinical application of therapeutically beneficial cord blood stem cells." "Throughout my career, I've come across many companies that have shown promise to elevate the use of cord blood to improve patient outcomes," said Dr. Miller. "The tools and technologies in BioE's portfolio are especially exciting and noteworthy because they directly address many issues related to working with cord blood that have limited the growth and adoption of this very valuable source of therapeutic cells. I welcome the opportunity to use my management and medical experience to help BioE further advance its tools and technologies, and develop a strong business around the application of cord blood." Additional Dr. Miller Background Dr. Miller is an assistant professor within the Department of Pathology and Laboratory Medicine at the University of Minnesota (body, education) University of Minnesota - The home of Gopher. http://umn.edu/. Address: Minneapolis, Minnesota, USA. . He has held a number of management positions applicable to the work BioE is undertaking with cord blood. Dr. Miller served as senior medical director of the American Red Cross' North Central Region National Cord Blood Program; was the acting CEO of the American Red Cross' North Central Region; and was medical director for the St. Paul National Testing Laboratory and the American Red Cross' Northern Ohio Region Blood services. In addition, he is a member of the Memorial Blood Centers board of directors, and serves on the American Association of Blood Banks' Cellular Therapies Committee; the Foundation for the Accreditation of Cellular Therapy's Collection Standards Committee; and NMDP's Standards and Cord Blood Committees. Dr. Miller holds numerous professional memberships; has had his work and opinions published extensively; and has received many accolades and honors, most recently the Herbert F. Polesky Award from the Memorial Blood Centers for his extraordinary and world-class contributions to improving the safety or availability of lifesaving blood. He holds doctorate of medicine and pharmacology degrees from the University of Connecticut The University of Connecticut is the State of Connecticut's land-grant university. It was founded in 1881 and serves more than 27,000 students on its six campuses, including more than 9,000 graduate students in multiple programs. UConn's main campus is in Storrs, Connecticut. School of Medicine, and a bachelor's degree in chemistry from Dartmouth College. Dr. Miller conducted his residency in clinical pathology at the University of Virginia. About BioE Headquartered in St. Paul, Minn., BioE is a biomedical company providing human cord blood stem cells as enabling, high-quality cellular tools for drug discovery and therapeutic research. The company's novel Multi-Lineage Progenitor Cell(TM) (MLPC MLPC Marxist-Leninist Party of Canada MLPC Midwest Lakes Policy Center (Madison, Wisconsin) MLPC Movement for the Liberation of the Central African People (Central African Republic) (TM)) -- derived from human umbilical cord blood umbilical cord blood Transplantation A source of primitive and stem cells that can be used to reconstitute BM destroyed by aplastic anemia or by RT or chemotherapy for CA, lymphoproliferative malignancies. See Bone marrow transplantation, Stem cell therapy. and obtained using PrepaCyte(R), the company's proprietary cell isolation platform -- provides clinicians and researchers a flexible, long-term and non-controversial tool for therapeutic research and drug discovery and screening. BioE is privately owned and was founded in 1993. For more information about the company, please visit www.bioe.com or call (800) 350-6466. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion